eFFECTOR Therapeutics, Inc. (EFTR)
(Delayed Data from NSDQ)
$1.60 USD
-0.10 (-5.88%)
Updated May 31, 2024 04:00 PM ET
After-Market: $1.60 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-1.74 | -16.43% |
Earnings Summary
For their last quarter, eFFECTOR Therapeutics, Inc. (EFTR) reported earnings of -$2.16 per share, beating the Zacks Consensus Estimate of $-2.17 per share. This reflects a positive earnings surprise of 0.46%. Look out for EFTR's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$1.74 per share, reflecting a year-over-year increase of 59.06%.
Earnings History
Price & Consensus
Zacks News for EFTR
Does eFFECTOR Therapeutics, Inc. (EFTR) Have the Potential to Rally 814.53% as Wall Street Analysts Expect?
EFTR: What are Zacks experts saying now?
Zacks Private Portfolio Services